Furosemide vs Pembrolizumab

Furosemide vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between Furosemide and Pembrolizumab.

Mechanism of Action

Furosemide: Loop diuretic inhibiting Na-K-2Cl cotransporter.

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Furosemide — 2 hours; Pembrolizumab — 26 days.

Chemical Properties

Molecular Formula: Furosemide — C12H11ClN2O5S.

Molecular Weight: Furosemide — 330.7440 g/mol.

Type: Furosemide — Small molecule; Pembrolizumab — Antibody.